CODX - Company ID 0001692415
The table below shows Co-Diagnostics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $145.95K | $145.38K | $162.91K | $50.28K | $641.14K | $2.66M |
| Cost of revenue | $193.77K | $26.29K | $32.11K | $21.59K | $297.40K | $212.15K |
| Gross profit | -$47.81K | $119.09K | $130.80K | $28.69K | $343.74K | $2.44M |
| R&D | $5.93M | $4.48M | $4.69M | $4.87M | $4.88M | $5.61M |
Co-Diagnostics, Inc. reported annual revenue of $622.49K for fiscal year 2025. That is down 84.1% from $3.92M in fiscal 2024. Over the 9 fiscal years shown, annual revenue grew from $7.66K (FY 2017) to $622.49K. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $2.50M | $1.82M | $2.60M | $2.77M | $4.29M | $3.13M |
| Operating income | -$9.21M | -$7.01M | -$8.06M | -$8.55M | -$10.23M | -$7.68M |
| Income tax | $520.00 | -$1.17M | $12.33K | $12.00K | $22.19K | $20.59K |
| Net income | -$9.14M | -$5.89M | -$7.73M | -$7.53M | -$9.70M | -$7.60M |
| EPS (diluted) | -$4.06 | -$0.16 | -$0.23 | -$7.05 | -$0.32 | -$0.25 |